Simplex Trading’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,707
Closed -$1.48M 9125
2025
Q4
$1.61M Buy
+55,707
New +$728K ﹤0.01% 2161
2025
Q2
Sell
-30,727
Closed -$325K 8698
2025
Q1
$291K Sell
30,727
-34,483
-53% -$479K ﹤0.01% 3945
2024
Q4
$899K Buy
+65,210
New +$1.14M ﹤0.01% 2943
2024
Q3
Sell
-17,169
Closed -$84.9K 8553
2024
Q2
$81K Sell
17,169
-8,028
-32% -$44.8K ﹤0.01% 5589
2024
Q1
$171K Sell
25,197
-17,543
-41% -$84.8K ﹤0.01% 5024
2023
Q4
$208K Buy
42,740
+5,959
+16% +$19.4K ﹤0.01% 4651
2023
Q3
$125K Buy
36,781
+26,635
+263% +$150K ﹤0.01% 4860
2023
Q2
$48K Buy
+10,146
New +$44.6K ﹤0.01% 5881
2023
Q1
Sell
-13,943
Closed -$60K 9082
2022
Q4
$53K Sell
13,943
-55,186
-80% -$263K ﹤0.01% 5806
2022
Q3
$414K Buy
69,129
+52,528
+316% +$269K ﹤0.01% 3682
2022
Q2
$57K Buy
16,601
+9,080
+121% +$32.2K ﹤0.01% 6307
2022
Q1
$25K Sell
7,521
-27,770
-79% -$110K ﹤0.01% 7974
2021
Q4
$103K Buy
35,291
+18,431
+109% +$64.6K ﹤0.01% 6199
2021
Q3
$85K Hold
16,860
﹤0.01% 6845
2021
Q2
$86K Buy
16,860
+12,231
+264% +$51.8K ﹤0.01% 6938
2021
Q1
$21K Buy
+4,629
New +$26.7K ﹤0.01% 7407
2020
Q3
Sell
-4,044
Closed -$23.6K 7812
2020
Q2
$18K Buy
+4,044
New +$17.6K ﹤0.01% 6284

Other funds holding CAPR

Simplex Trading's CAPR Position: Q1 2026 in Review

Simplex Trading sold out of Capricor Therapeutics (CAPR) in Q1 2026, closing a stake of 55,707 shares — an estimated $1.48M sold.

Simplex Trading first reported a position in CAPR in Q2 2020 and held it in 17 quarters. The position peaked at $1.61M in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Simplex Trading reported no remaining Capricor Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 55,707 Capricor Therapeutics shares in Q1 2026, an estimated $1.48M.
  • Simplex Trading first reported a position in Capricor Therapeutics in Q2 2020 and held it in 17 quarters.
  • Simplex Trading's Capricor Therapeutics position peaked at $1.61M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.